DNMT1 and cancer: Indeed, there are several cancer drugs approved by FDA, such as 5-azacytidine and decitabine that act as DNA methyltransferase (DNMT) inhibitors or SAHA and romidepsin that act as histone deacetylase (HDAC) inhibitors (Rius and Lyko, 2012).